Abstract
According to this study: The antiviral remdesivir is superior to placebo in the treatment of patients hospitalized with COVID-19.A variety of therapeutic approaches are needed to continue to improve outcomes in COVID-19 patients.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Adenosine Monophosphate / analogs & derivatives*
-
Adenosine Monophosphate / therapeutic use
-
Alanine / analogs & derivatives*
-
Alanine / therapeutic use
-
Antiviral Agents / therapeutic use*
-
COVID-19 Drug Treatment*
-
Double-Blind Method
-
Female
-
Humans
-
Male
-
Middle Aged
Substances
-
Antiviral Agents
-
remdesivir
-
Adenosine Monophosphate
-
Alanine